*-,
*",",'
,,",
-

,138,-""
.147-144
',2000,'

[1
]Scott-1981-
堠.
.(),

.,


7-Clostridiumbotulinum
.[3,2
]GA
60%
-A.
.
.-
A
-
-.
.
,堠
.
.䠠
,.
A
,

A.
.[6-3
]--
,
,
(sprouting)-(motorendplates)
.[3
]
.䠠
-,
Botox®:
SpeywoodDysport®-AllerganInc.,USA
(units).Pharmaceuticals,England
.[7]LD5050%
.100



[8]'Scott.
[9
]'Herrero."39-
'
Scott.,40-,

,"70
-,."33-,
.400
300.3000-
21

.[3
]


A-®7%4%-
..[12-10
]
,
invivo
.[15],[14,13]
.[12
]젠
.
-,
.
C-F,B.
.
A[18-16,12]


,,,A
.
86%
[20]'.[19]
.92%
-blepharospasm-
.䠠
,-
.-
6
A
,,
.


,
.
,.
.
,
..
,
.
.[21
]-,
,
,.
.[22,21
]
,
.
.-""
.,,
A
,.
.,
.


®
(contractures).
®.
.
5

.,
.
.,

.[21
]
,
,.
.
.
.[23
]-
.

,,.[24
]
A.[25]EMG
.[26
]
A[21]Graham-Boyd
,,A.
.5

.


.[27]8-3®
.
.
,
.[21
]
3
-
.


,A
.
.[28,23
],
."4
-.
"16-12

.[28,23,21,3
]300
,
gastrocnemius-,,
.
..[29,21
]

.[31-29
]
.[23
]
,
.[26,21
]

-
.[27]®
,,
.[13
].
-,
,.
.[23
]
,18
,
,
.[29,26,23
]


,[32,29]'Koman
[35-33,28-26
],
.
[28
]'Koman2-
.
®70%(
.49.5%
-
3.8
-
14
[36]'.(
.7
-.9-

A,
.
.
,-
.,

.
.



1.
ScottAB.Botulinumtoxininjectionofeyemusclestocorrectstrabismus.TransAm
OphthalmolSoc.1981;79:734-770.
2.
SimpsonLL.KineticstudiesontheinteractionbetweenbotulinumtoxintypeAand
cholinergicneuromuscularjunction.J.PharmacolExpTher.1980;212:16-21.
3.
BrinMF.Botulinumtoxin:chemistry,pharmacology,toxicityandimmunology,Muscle
Nerve.1997;20(suppl6):146-168.
4.
DollyJO.Generalpropertiesandcellularmechanismsofneurotoxins.In:JankovicJ.Haller
M.(eds.),TherapywithBotulinumToxin.NewYork,MarcelDekker,1994.
5.
GundersenCB.Theeffectsofbotulinumtoxinonthesynthesis,storageandreleaseof
acetylcholine.Prog.Neurobiol.1980;14:99-119.
6.
SimpsonLL.Peripheralactionsofthebotulinumtoxins.In:SimpsonLL(ed.),Botulinum
NeurotoxinandTetanusToxin.NewYork,AcademicPress,1989,pp.153-178.
7.
SellinLC&Theslefs.Preandpost-synapticactionsofbotulinumtoxinattherat
neuromuscularjunction.J.Physiol.1981;317:487-495.
8.
ScottAB&SuzukiD.SystemicToxicityofbotulinumtoxinbyintramuscularinjectioninthe
moneky.Mov.Disord.1985;3:333-335.
9.
HerreroBA,EcklundAE,StreetCS&al.Experimentalbotulisminmonkeys:aclinical
pathologicalstudy.ExpMolPathol.1967;6:84-95.
10.
GreeneP&FahnS.DevelopmentofantibodiestobotulinumtoxinAinpatientswith
torticollistreatedwithinjectionsofbotulinumtoxintypeA.In:DasGuptaBR(ed.),
BotulinumandTetanusNeurotoxins.NewYork.PlenumPress,1993,pp.651-654.
11.
GreeneP,FahnS&DimondB.DevelopmentofresistancetobotulinumtoxintypeAin
patientswithtorticollis.Mov.Disord.1994;9:213-217.
12.
JankovicJ&SchwartzK.Responseandimmunoresistancetobotulinumtoxininjections.
Neurology,1995;45:1743-1746.
13.
IamannaC,ElHageAN&......JA.Cardiaceffectsofbotulinumtoxin.ArchInt
PharmacodynTher.1988;293:69-83.
14.
LangeDJ.Systemiceffectsofbotulinumtoxin.In:JankovicJ.HalletM(ed.),Therapywith
BotulinumToxin.NewYork,MarcelDekker.1994,pp.109-118.
15.
DoellgastGJ,BeardGA.BottomsJD&al.Enzyme-linkedimmunosorbentassayand
enzyme-linked-coagulationassayfordetectionofclostridiumbotolinumneurotoxinA.
neurotoxinB.andneurotoxinEandsolutionphasecomplexeswithduallabelantibodies.J
Clin.Microbiol.1994;32:105-111.
16.
GreenePE&FahnS.UseofbotulinumtoxintypeFinjectionstotreattorticollisinpatients
withimmunitytobotulinumtoxintypeA.Mov.Disord.1993;8:479-483.
17.
LewMF,AdornatoBT,DuancDD&al.BotulinumtoxintypeB.adouble-blind.
Placebo-controlled.safetyandefficacystudyincervicaldystonia.Neurology,1997;
49(3):701-707.
18.
SloopRR,ColeBA&EscutinRO.HumanresponsetobotulinumtoxininjectiontypeB
comparedwithtypeA.Neurology,1997;49:189-194.
19.
JankovicJ&BrinMF.Botulinumtoxin;historicalperspectiveandpotentialnewindications.
MuscleNerve.1997;20(suppl6):129-145.
20.
GiladiN,MeerJ,KidanC&al.Interventionalneurology:botulinumtoxinasapotent
symptomatictreatmentinneurology.IsrJ.MedSci.1994;30:816-....
21.
BoydR&Graham,HK.BotulinumtoxinAinthemanagementofchildrenwithcerebral
palsy:indicationandoutcome.EuropeanJNeurol.1997;4(suppl2):15-22.
22.
TardieuC,TaharyJC,TaharyC&Huetdela.....E.Comparisonofthesarcomerenumberof
youngandadultanimals,J.Physiol.1997;73:1045-1055.
23.
GrahamHK.BotulinumtoxintypeAincerebralpalsy:indicationsandoutcomes.The4th
EuropeanBotulinumToxinSymposioum.Abstracts.Vienna,1999;6.
24.
GoochJL&SandellTV;Botulinumtoxinforspasticityandathetosisinchildrenwith
cerebralpalsy,ArchPhysMedRehabil.1996;77:508-511.
25.
O'BrienCF.Injectiontechniquesforbotulinumtoxinusingelectromyographyandelectrical
stimulation.MuscleNerve.1997;20(suppl6):176-180.
26.
CorryIS,CosgroeAP,WalstEG&al.BotulinumtoxinAinthehemiplegicupperlimb:a
doubleblindtrial.Dev.MedChildNeurol.1997;39:185-193(abstract).

27.
RussmanBS,TiltonA&.......JrME.Cerebralpalsy:arationalapproachtoatreatment
protocolandtheroleofbotulinumtoxinintreatment.MuscleNerve.1997;20(suppl
6):181-193.
28.
KomanLA,MooneyJF,Paterson-SmithB&WalkerFO.Short-tolongtermeffectsof
botulinumtoxintypeAonequinusfootdeformityincerebralpalsy.The4thEuropean
BotulinumToxinSymposium,Abstracts,Vienna,1999,pp.10-11.
29.
KomanLA,MooneyJF,SmithBP&al.Managementofspasticyincerebralpalsywith
botulinumAtoxin:reportofapreliminary,randomized,doubleblindtrial.JPedOrthop.
1994;14:299-303.
30.
ChutorianA&RootL.ManagementofspasticityinchildrenwithbotulinumAtoxin.Intl
Pediatrics.1994;9:35-43.
31.
ChutorianA&RootL.BTAstudygroup:amulti-centrered,randominzed.double-blind
placebocontrolledtrialofbotulinumtoxintypeAinthetreatmentoflowerlimbspasticityin
pediatriccerebralpalsy.Mov.Disord.1995;10:364(abstract).
32.
KomanLA,MooneyJF3d,SmithB&al.Managementofcerebralpalsywithbotulinum-A
toxin:preliminaryinvestigation.JPediatrOrthop.1993;13:489-95.
33.
CosgroveAP,CorryIS&Graham,HK.Botulinumtoxininthemanagementofthelower
limbincerebralpalsy.DevMedChildNeurol.1994;36:386-96.
34.
DenislieM&MehD.Botulinumtoxininthetreatmentofcerebralpalsy.Neuropediatrics.
1995;26:249-52.
35.
DunneJH,HeyeN&DunneSL.Treatmentofchroniclimbspasticitywithbotulinumtoxin
A.J.NeurolNeurosurgPsychiatry,1995;58:232-5.
36.
ZelnikN,GiladiN,GotkhmanI&al.Theroleofbotulinumtoxininthetreatmentoflower
limbspasticityinchildrenwithcerebralpalsy-apilotstudy.IsrJMedSci.1997;
33:129-133.

.""


top


telem
Copyright,TheOpenUniversityofIsrael1997-2000Allrightsreserved
.-2000"
webmaster@telem.openu.ac.il: